China Biologic Products, Inc. has a contract to ship $1.6 million worth of its plasma-based products to India. The products, which will be sold under China Biologic’s name, have been registered under the Central Drugs Standard Control Organization (CDSCO), the drug control administration in India. China Biologic recently began an initiative to ramp up its international sales. More details...

Stock Symbol:  (OTCBB: CBPO)